PAHC

Phibro Animal Health Corporation

9.88 USD

Last updated Dec 3, 01:17 UTC

Yesterday HIGH

$10.02

Yesterday LOW

$9.5

52w HIGH

$16.52

52w LOW

$9.4

EPS

0.14

PE

70.57

Next Earnings

Feb 7, 2024

Overview News Government Trades

Phibro Animal Health Corporation stock is down -16.48% since 30 days ago. The next earnings date is Feb 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70% of the previous 9 December’s closed higher than November. 0% of analysts rate it a buy.

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Teaneck, United States Of America

Website

pahc.com

Benzinga Insights

Wed May 3, 2023

Recap: Phibro Animal Health Q3 Earnings
Benzinga Newsdesk

Wed May 3, 2023

Phibro Animal Health Sees FY23 Net Sales $960M-$1B Vs $984.98M Est; Sees Adj. EPS $1.21-$1.31 Vs $1.24 Est
Benzinga Newsdesk

Wed May 3, 2023

Phibro Animal Health Q3 Adj $0.29 Misses $0.33 Estimate, Sales $245.70M Miss $247.46M Estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.33 by 12.12 percent. This is a 12.12 percent decrease over earnings of $0.33 per share
Benzinga Insights

Fri Feb 10, 2023

Phibro Animal Health's Return On Capital Employed Insights
Benzinga Newsdesk

Thu Feb 9, 2023

Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Lowers Price Target to $19

Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and lowers the price target from $20 to $19.
Benzinga Newsdesk

Wed Feb 8, 2023

Phibro Animal Health Q2 EPS $0.34 Beats $0.30 Estimate, Sales $244.60M Beat $241.28M Estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.30 by 13.33 percent. This is a 8.11 percent decrease over earnings of $0.37 per share from
Benzinga Insights

Wed Feb 8, 2023

Earnings Scheduled For February 8, 2023

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its fourth quarter. • Bunge (NYSE:BG) is projected to report quarterly earnings at $3.22 per share on revenue of $18.22 billion.
Benzinga Insights

Wed Dec 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Benzinga Newsdesk

Wed Dec 21, 2022

Roth Capital Initiates Coverage On Phibro Animal Health with Buy Rating, Announces Price Target of $18

Roth Capital analyst Brian Wright initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Buy rating and announces Price Target of $18.
Benzinga Insights

Tue Dec 13, 2022

Phibro Animal Health's Return On Capital Employed Overview